DISTAL POLYNEUROPATHY IN TYPE 2 DIABETIC PATIENTS: PATHOGENETIC THERAPY BY BERLITION

Authors

DOI:

https://doi.org/10.21856/j-PEP.2012.2.06

Keywords:

type 2 diabetes, distal polyneuropathy, lipoic acid, Berlition

Abstract

Own data on α-lipoic acid (Berlition) therapy (1200 mg/day) for distal polyneuropathy treatment in type 2 diabetics are presented. Our findings suggest efficiency and safety of such pathogenesis therapy by significant reduction of clinical symptoms of neurologic deficiency and touch insufficiency due to tactile and painful sensitivity improvement.

References

Vinik, A. Diagnosis and Management of Diabetic Neuropathy [Text] / A. Vinik // Can. J. Diabetes Care. — 2000. — № 24. — P. 56–76.

The DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy [Text] // Ann. Intern. Med. — 1995. — Vol. 122. — P. 561–568.

Синдром диабетической стопы: клиника, диагностика, лечение и профилактика [Текст] / И. И. Дедов, М. Б. Анциферов, Г. Р. Галстян, А.Ю. Токмакова. — М., 1998. — 138 c.

Sima, A. A. F. Experimental diabetic neuropathy: an update [Text] / A. A. F. Sima, K. Sugimoto // Diabetologia. — 1999. — Vol. 42. — P. 773–778.

Brownlee, M. Biochemistry and molecular cell biology of diabetic complications [Text] / M. Brownlee // Nature. — 2001. — Vol. 414. — P. 813–820.

Baynes, J. W. Oxidative stress in diabetes [Text] / J.W. Baynes, S. R. Thorpe // Antioxidants in diabetes management / Ed. by L. Packer. — N. Y.: M. Dekker Inc., 2000. — P. 77–92.

Antioxidants in disease mechanisms and therapy [Text] / Ed. by H. Sies. — Academic Press, 1997. — 695 p.

Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study [Text] / I. Strokov, T. Bursa, O. Drepa [et al.] / Acta diabetologica. — 2003. — Vol. 40 (Suppl. 2). — P. 375–379.

Аметов, А. С. Диабетическая полинейропатия: настоящее и будущее [Текст] / А. С. Аметов, И. А. Строков // Российские медицинские вести. — 2001. — Т. 6, № 1. — С. 35–40.

Лечение диабетической полиневропатии [Текст] / И. Строков, А. Баринов, М. Новосадова [и др.] // РМЖ. — 2001. — Т. 9, № 7–8. — С. 314–317.

Fernyhough, P. Mitochondrial stress and the pathogenesis of diabetic neuropathy [Text] / P. Fernyhough, R. Chowdhury, R. E. Schmidt / Expert. Rev. Endocrinol. Metab. — 2010. — Vol. 5, № 1. — P. 39–49.

Метаболизм альфа-липоевой кислоты в печени при различных формах патологии [Текст] / Д. Бустаманте, Д. Лодж, Л. Маркоччи [и др.] // Междунар. мед. журн. — 2001. — № 2. — С. 133–142.

Evans, J. L. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes [Text] / J. L. Evans, I. D. Goldfine // Diabetes. Technol. Ther. — 2000. — Vol. 2, № 3. — P. 401–413.

Antioxidants in diabetes Management [Text] / Ed. by L. Packer. — N. Y.: M. Dekker Inc., 2000. — 368 p.

Effect of treatment with the antioxidant alpha-lipoid acid in cardiac autonomic neuropathy in NIDDM patiemts (DECAN Study) [Text] / D. Ziegler, H. Schatz, F. Conrad [et al.] // Diab. Care. — 1997. — № 20. — P. 369–373.

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3- week multicentre randomized controlled trial (ALADIN Study). [Text] / D. Ziegler, M. Hanefeld, K. J. Ruhnau [et al.] // Diabetologica. — 1995. —

Vol. 38. — P. 1425–1433.

Alfa-Lipoic acid in the treatment of diabetic polyneuropathy in Germany current evidence front clinical trails [Text] / D. Zyegler, M. Reljanovic, H. Mehnert [et al.] / Exp. Clin. Endocrinol. Diabetes. — 1999. — Vol. 107. — P. 421–430.

Untersuchungen zur Bioverfugbarkeit von alphLiponsare by Typ-I und Typ-II Diabetikern mit Diabetischer Neuropathie [Text] / C. Rosak, P. Hoffgen, W. Batles [et al.] / Diabetes Schtoffwechsel. — 1996. — № 3 (suppl. 5). — P. 23–26.

Alph-Liponsare (Thioctsaure) — aktueller Stand zur enantioselektiven Pharmkokinetic dei Gesunden und Diabetikern [Text] / R. Hermann, C. Gleiter, G. Nibch [et al.] / Diabetes Schtoffwechsel. — 1996. — № 3 (suppl. 5). — P. 5–11.

Influence of food intake on the bioavailability of thioctic acid enantiomers [Text] / C. Gleiter, B. Schug, R. Hermann [et al.] / Eur. J. Clin. Pharmacol. — 1996. — Vol. 50. — P. 513–514.

Ziegler, D. Treatment of diabetic neuropathy and neuropathic pain: how far have we come? [Text] / D. Ziegler // Diabetes Care. — 2008. — Suppl. 2. — S. 255–261.

Huang, E. A. The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus [Text] / E. A. Huang, S. E. Gitelman // Pediatr. Diabetes. — 2008. — № Pt 2. — P. 69–73.

Bureković, A. The role of alpha-lipoic acid in diabetic polyneuropathy treatment / A. Bureković, M. Terzić, S. Alajbegović [Text] / Bosn. J. Basic. Med. Sci. — 2008. — Vol. 8, № 4. — P. 341–345.

Quantitative sensory testing: a consensus report from the Peripheral Neuropathy Association [Text] // Neurology. — 1993. — Vol. 43. — P. 1050–1052.

Dyck, R. J. Detection, characterization, and staging of polyneuropathy: assessed in diabetics [Text] / R. J. Dyck // Muscle & Nerve. — 1988. — Vol. 11. — P. 21–32.

Современное лечение диабетической нейропатии [Текст]: метод. рекомендации / МОЗ Украины; [авт. Н. Д. Тронько, В. Г. Науменко]. — К., 2000. — 16 с.

Downloads

Published

2012-06-04

How to Cite

Khyzhnyak, O., & Mykytyuk, M. (2012). DISTAL POLYNEUROPATHY IN TYPE 2 DIABETIC PATIENTS: PATHOGENETIC THERAPY BY BERLITION. Problems of Endocrine Pathology, 40(2), 32-39. https://doi.org/10.21856/j-PEP.2012.2.06

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)

1 2 > >>